ChanTest Acquired by Charles River Laboratories International, Inc.

CLEVELAND, OH – Oct. 29, 2014 –  ChanTest, a leading provider of specialized laboratory testing services for drug development, and portfolio company of Ampersand Ventures,  has been acquired by life sciences research giant Charles River Laboratories International, Inc. (NYSE: CRL) for a total price of $54 million. ChanTest specializes in measuring interactions between drug candidates […]

Fairmount Partners Assists Micron in Deal with Catalent

SOMERSET, NJ – November 14, 2014 – Catalent, Inc. (NYSE:CTLT), the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, has acquired Micron Technologies, a leading global provider of particle size engineering technologies.  Micron Technologies was a portfolio company of Arlington Capital Partners, a Washington, D.C.-based private […]